Search for: "C Lillie" Results 301 - 320 of 444
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Jul 2011, 8:27 am by admin
  You know where we stand   Two days later, on the first clear day of the week, about 40 neighborhood residents, informally known as Chelsea Moms, assembled behind police barricades around the corner from the bank, outside the office of Christine C. [read post]
6 Jul 2011, 2:21 am by Marie Louise
  General Traditional knowledge and genetic resources – developing IPRs – 19 developing nations meet in Bali (IP Komodo Dragon) Twelve more nations, EU, sign Nagoya Protocol (IP Watch) Australia: Update on Australian Senate gene patent inquiry (Patentology) Canada: Amending Canada’s Access to Medicines Regime (CAMR): The new fate of Bill C-393 (IP Watch) EU: Negative term SPC – A handy note on Case C-125/10 Merck (The SPC Blog) (EPLAW) Italy: Milan… [read post]
24 Jun 2011, 3:25 pm by Christa Culver
This edition of “Petitions to watch” features cases up for consideration at the Justices’ June 23 Conference. [read post]
24 Jun 2011, 4:33 am by INFORRM
  In Lillie & Reed v Newcastle City Council [2002] EWHC 1600 (QB) two nursery nurses were wrongly accused of paedophilia. [read post]
15 Jun 2011, 4:56 am by Marie Louise
(Patent Docs) Strattera (Atomoxetine)- US: Patent infringement complaint filed in response to Para IV certification: Eli Lilly & Co. v. [read post]
13 Jun 2011, 5:32 pm by FDABlog HPM
(CC) The patent information submitted under [FDC Act § 505(b) or (c)] is withdrawn by the holder of the application approved under subsection (b). [read post]
9 Jun 2011, 10:02 am by Bexis
Eli Lilly & Co., 2009 WL 5216930, at *12 (E.D.N.Y. [read post]
6 Jun 2011, 1:30 pm by Tom Lamb
Victoza is in the same class of drugs as Byetta (marketed by Amylin Pharmaceuticals and Eli Lilly) and Januvia (marketed by Merck). [read post]
2 Jun 2011, 12:46 pm by Bexis
It was the last blank space on the legal map – the only state with no precedent whatsoever. [read post]
4 May 2011, 4:13 am by Marie Louise
(Docket Report) Provigil (Modafinil) – EU announces anti-trust probe into a Cephalon – Teva deal concerning generic Provigil (The IP Factor) (GenericsWeb) Valsartan – Norway: District Court of Oslo forbids Actavis to market any products containing Valsartan produced by using the process QSSA Route C until 13 May 2011 (EPLAW) Welchol (Colesevelam) – US: Daiichi Sankyo, Genzyme file patent infringement complaint against Watson in response to Para IV certification… [read post]
28 Apr 2011, 3:18 pm by Bexis
  Rather, “[c]ourts must decide the applicability of comment k case-by-case, and only after taking evidence related to the various factors. [read post]